查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371900

到 2030 年眼睑手术市场预测：按类型、性别、服务提供者和地区分類的全球分析

Blepharoplasty Market Forecasts to 2030 - Global Analysis By Type (Upper Eyelid Blepharoplasty, Lower Eyelid Blepharoplasty and Combination Eyelid Surgery), Gender, Service Provider and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球眼睑手术市场规模为 40.8 亿美元，预计预测期内年复合成长率为 9.6%，到 ​​2030 年将达到 77.5 亿美元。

称为眼睑手术的外科手术旨在改善眼睑的外观，特别是上眼睑、下眼睑或两者。这种整容手术可以打造更年轻、更清爽的外观，并经常用于解决与眼睑老化相关的众多问题。眼睑手术经常用于解决老化症状，例如眼睛周围下垂、皮肤多余、皱纹和浮肿。除了美容功效外，眼睑手术还可以帮助解决实际问题，例如上眼睑下垂引起的视力障碍。有些人进行眼睑手术是为了改善脸部的整体外观，使其看起来更年轻。

英国美容整形外科医师协会进行的研究发现，在封锁期间，虚拟手术咨询的请求激增了 70%，为封锁后的面对面治疗做准备。

高龄化社会对手术的需求不断增加

人口高龄化、可支配所得增加以及改善外表的愿望都促进了这一增长。此外，这种治疗方法在美国以外的地区也越来越受欢迎，包括中国、日本和韩国。由于眼睑手术需求的增加，包括非侵入性手术和最尖端科技在内的新型治疗方法的开发也促进了该行业的扩张。高龄化人口保持年轻外表的愿望是眼睑手术的主要市场驱动力，预计这一趋势将持续下去，支持市场扩张。

成本高

在美国，眼睑手术的典型费用各不相同，取决于手术范围、外科医生的能力和地点等因素。有些潜在患者可能会因为手术费用过高而犹豫是否接受手术，特别是如果他们没有足够的健康保险或可支配所得。此外，手术可能会产生感染、出血和疤痕等副作用，这会阻碍患者接受治疗并阻碍市场成长。

使用新手术技术进行客製化

由于手术方法和技术的改进，眼睑手术变得更安全、更有效。该手术因其微创技术、恢復快、效果好而越来越受欢迎。眼睑手术整形手术可以根据每位患者的独特要求和目标进行客製化。例如，外科医师可以调整手术程序来治疗特定病症，例如上眼睑下垂、下眼睑浮肿或问题的组合。此外，由于等离子技术和雷射辅助设备等技术的发展，市场正在扩大。这些装置提供精确且受控的组织消融和收紧，对邻近组织几乎没有伤害。

由于健康保险的覆盖范围而引起的安全担忧

引人注目的眼睑手术相关问题和不利事件可能会破坏公众的信任并拒绝潜在的患者。安全问题可能会导致监督和法规的加强。对于某些患者来说，进行眼睑手术整形手术可能会因保险范围有限或不存在而受到阻碍。潜在的患者可能会因为手术的自付费用而望而却步，尤其是对于那些预算紧张的患者。整容手术（尤其是眼睑手术术）法律的变化可能会影响市场。收紧法规和许可要求可能会增加执业成本并减少从业人员数量。

COVID-19 的影响

COVID-19 的爆发扰乱了全球医疗保健产业的运作。眼睑手术受到了 COVID-19大流行的显着影响。世界上多个国家实施了严格的封闭和社会隔离政策，限制了获得医疗服务的机会，并减少了选择眼睑手术的患者数量。

预测期内上眼睑眼睑手术领域预计将是最大的

上眼睑眼睑手术术预计会有良好的生长，因为它是一种旨在改善上眼睑外观的整容手术。这种手术经常用于治疗由老龄化、遗传和其他因素引起的各种美学问题。透过解决上眼睑多余的皮肤和皱纹、影响视力的上眼睑上垂或下垂以及上眼睑区域浮肿或凸起的脂肪沉积等问题，上眼睑眼睑手术可以帮助您看起来更年轻。使外观焕然一新，正在推动眼睑手术市场的成长。

医院部门预计在预测期内年复合成长率最高

由于在医院接受整容手术的患者数量不断增加以及使用尖端医疗技术提供眼睑手术的医院数量不断增加，预计医院领域在预测期内将以最高的年复合成长率增长。医院工作人员将提供术后治疗和指导，包括疼痛管理、开放性伤口护理以及减少肿胀和瘀伤的建议。一旦患者病情稳定并清醒，他们通常就会出院。医院工作人员和外科医生通常会向患者提供详细的术后说明，包括有关眼部护理、药物和早期復健期间应避免的活动的资讯。

占比最大的地区：

预计亚太地区在预测期内将占据最大的市场占有率。这是由于该地区製药和医疗设备製造商的存在以及中国和印度等国家老年人口的增加，这些都是促进该地区市场成长的因素。此外，由于人们对微创手术的意愿日益增加，眼睑手术市场预计将在预测期内成长。双眼皮手术是亚洲国家（尤其是韩国）最受欢迎的手术，推动了该地区的市场成长。

复合年复合成长率最高的地区：

由于该地区存在几个重要的主要企业以及医疗设备技术的快速进步，预计北美在预测期内将呈现最高的年复合成长率。市场扩张的主要驱动力是越来越多的人接受眼睑手术术治疗，以使用创新和复杂的美容技术（包括雷射换肤和真皮填充剂）来改善眼睛的外观。这就是我正在做的事情。例如，根据2021年国际美容整形外科外科学会报告，美国完成了53,253例眼睑整形手术，而美国估计完成了149,668例眼睑整形手术；促进了区域市场成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球眼睑手术市场：依类型

  • 上眼睑手术
  • 下眼睑手术
  • 混合眼睑手术

第6章全球眼睑手术市场：性别

  • 女士
  • 男性

第7章全球眼睑手术市场：依服务提供者分类

  • 医院
  • 诊所
  • 门诊手术中心

第8章全球眼睑手术市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Abbvie Inc
  • Allergan
  • Alma Lasers
  • Cynosure
  • Erchonia Corporation
  • Galderma
  • Grand Aespio Inc.
  • Hologic
  • Johnson & Johnson
  • LightScalpel
  • London Bridge Plastic Surgery
  • Lumenis
  • MA Corporation
  • Medline industries, inc.
  • Medtronic plc
  • Merz Pharma
  • Sientra
  • Sisram Medical Ltd
  • Surgical Holdings Ltd.
  • Valeant Pharmaceuticals International
  • Zimmer Biomet
Product Code: SMRC23957

According to Stratistics MRC, the Global Blepharoplasty Market is accounted for $4.08 billion in 2023 and is expected to reach $7.75 billion by 2030 growing at a CAGR of 9.6% during the forecast period. A surgical technique called blepharoplasty aims to improve the appearance of the eyelids, specifically the upper, lower, or both. This cosmetic procedure can produce a more young and refreshed appearance and is frequently used to address numerous issues connected to the aging of the eyelids. In order to address aging symptoms such sagging or extra skin, wrinkles, and puffiness around the eyes, blepharoplasty is frequently performed. In addition to its cosmetic advantages, blepharoplasty can help with practical problems including visual impairment brought on by sagging upper eyelids. Some people get blepharoplasty to make their face look better overall and look more youthful.

According to a study conducted by the British Association of Aesthetic Plastic Surgeons, requests for virtual consultations for surgical procedures jumped by 70% during the lockdown in preparation for in-person treatment following the lockdown.

Market Dynamics:

Driver:

Increasing demand for the surgery among the aged population

The aging of the population, rising disposable money, and the desire to improve one's look are all contributing causes to the growth. Furthermore, the treatment is becoming more and more popular outside of the United States as well, including in China, Japan, and South Korea. The development of novel treatments, including non-invasive procedures and cutting-edge technologies, as a result of the increasing demand for blepharoplasty has also helped the industry expand. The aging population's desire to maintain a youthful appearance is a major market driver for blepharoplasty, and this trend is anticipated to persist in the years to come, supporting market expansion.

Restraint:

High cost

Depending on the degree of the procedure, as well as other elements including the surgeon's competence and location, the typical cost of blepharoplasty surgery in the United States varies. Some prospective patients are discouraged from having the surgery because of its exorbitant cost, especially those who lack sufficient health insurance or disposable income. Additionally, there is a chance that the surgery can have side effects like infection, bleeding, and scarring, which discourages patients from having the treatment done which hamper the growth of the market

Opportunity:

Customization utilizing new surgical methods

Blepharoplasty has become safer and more efficient thanks to improvements in surgical methods and technology. The operation is becoming more and more popular, in part because of minimally invasive techniques, quick recoveries, and better results. Procedures for blepharoplasty can be customized to each patient's unique requirements and objectives. In order to treat specific symptoms, such as upper eyelid sagging, lower eyelid puffiness, or a combination of problems, surgeons might tailor the procedure. Additionally, the market is expanding as a result of technological developments such plasma technology and laser-assisted devices, which offer precise and controlled tissue ablation and tightening with little harm to neighbouring tissues.

Threat:

Safety concerns with health insurance coverage

High-profile blepharoplasty-related problems or adverse events can damage public confidence and turn away potential patients. There may be more oversight and regulations as a result of safety concerns. For certain patients, access to blepharoplasty procedures may be hampered by limited or non-existent insurance coverage. Potential patients may be discouraged by the procedure's out-of-pocket cost, especially those who are on a limited budget. The market may be impacted by modifications to laws governing cosmetic surgery, especially blepharoplasty. Stricter rules or licensing requirements may raise the cost of practicing and reduce the availability of practitioners, which may have an impact on how accessible the treatment and the market.

COVID-19 Impact

The COVID-19 outbreak has hampered operations in the global healthcare industry. Blepharoplasty surgery has been significantly impacted by the COVID-19 pandemic. Strict lockdowns and social segregation policies have been put in place by several nations around the world, which have disrupted access to healthcare services and lowered the number of patients choosing to have blepharoplasty.

The upper eyelid blepharoplasty segment is expected to be the largest during the forecast period

The upper eyelid blepharoplasty segment is estimated to have a lucrative growth, as it is a type of cosmetic surgery that aims to improve the appearance of the upper eyelids. This surgery is frequently used to treat a variety of aesthetic issues brought on by aging, heredity, or other factors. By addressing concerns like extra skin and wrinkles on the top eyelids, hooded or drooping upper eyelids that may impair vision, and puffy or bulging fat deposits in the upper eyelid area, upper eyelid blepharoplasty aims to produce a more youthful and rejuvenated appearance thus driving the growth of the blepharoplasty market.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period, due to the rise in patients having cosmetic surgery performed at hospitals as well as the increase in hospitals offering surgical procedures for the eyelid using cutting-edge medical technology. The postoperative treatment and instructions are given by hospital staff and may include recommendations for managing pain, caring for open wounds, and lowering swelling and bruising. Once a patient is stable and awake, they are typically released detailed postoperative instructions, including information on eye care, drugs, and activities to avoid during the early recovery phase, are frequently given to patients by hospital staff and surgeons.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the presence of pharmaceutical and medical device manufacturers in the area, as well as the increase in the geriatric population in nations like China and India, are both responsible for the market growth in this area. an increase in the number of elderly people, a rise in the number of people who have saggy or droopy upper eyelids as a result of sedentary lifestyles, and an increase in screen time as a result of the COVID-19 epidemic. Additionally, it is anticipated that the market for blepharoplasty would experience rise throughout the projection period because to the growing inclination for minimally invasive procedures. Double eyelid surgery is the most popular procedure in several Asian nations, particularly in Korea enhances the market growth in this region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the existence of several significant key players and the rapid technological advancement of medical devices in this area. The main driver of the market's expansion is the rise in the number of people having blepharoplasty treatments to enhance the appearance of their eyes using innovative and sophisticated cosmetic techniques including laser resurfacing and dermal fillers. For instance, a report from the International Society of Aesthetic Plastic Surgery from 2021 estimates that 149,668 eyelid surgery treatments were completed there, compared to 53,253 in the U.S. which are propelling the growth of the regions market.

Key players in the market:

Some of the key players profiled in the Blepharoplasty Market include: Abbvie Inc, Allergan, Alma Lasers, Cynosure, Erchonia Corporation, Galderma, Grand Aespio Inc., Hologic, Johnson & Johnson, LightScalpel, London Bridge Plastic Surgery, Lumenis, M A Corporation, Medline industries, inc., Medtronic plc, Merz Pharma, Sientra, Sisram Medical Ltd, Surgical Holdings Ltd, Valeant Pharmaceuticals International and Zimmer Biomet.

Key Developments:

In October 2023, Allergan Aesthetics and Girls Inc. partner to speed the entry of young Women into Positions of Leadership in the STEM Field. The Allergan Aesthetics effort will focus specifically on leadership paths in STEM (science, technology, engineering, and math).

In October 2023, Johnson & Johnson Company announced a development and commercialization agreement with Sanofi for Janssen's extraintestinal pathogenic Escherichia coli (ExPEC) investigational vaccine program. The lead vaccine candidate is currently being evaluated in the Phase 3 E.mbrace study for the prevention of invasive E. coli disease (IED) in adults aged 60 years and older.

In July 2023, AbbVie and Calibr expand strategic collaboration to advance several preclinical and early-stage clinical assets. This partnership is an expansion of the collaboration AbbVie and Scripps Research formed in 2019 to develop a broad range of potential new and novel therapeutics.

Types Covered:

  • Upper Eyelid Blepharoplasty
  • Lower Eyelid Blepharoplasty
  • Combination Eyelid Surgery

Genders Covered:

  • Female
  • Male

Service Providers Covered:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centre

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Blepharoplasty Market, By Type

  • 5.1 Introduction
  • 5.2 Upper Eyelid Blepharoplasty
  • 5.3 Lower Eyelid Blepharoplasty
  • 5.4 Combination Eyelid Surgery

6 Global Blepharoplasty Market, By Gender

  • 6.1 Introduction
  • 6.2 Female
  • 6.3 Male

7 Global Blepharoplasty Market, By Service Provider

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Ambulatory Surgical Centre

8 Global Blepharoplasty Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.8 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbvie Inc
  • 10.2 Allergan
  • 10.3 Alma Lasers
  • 10.4 Cynosure
  • 10.5 Erchonia Corporation
  • 10.6 Galderma
  • 10.7 Grand Aespio Inc.
  • 10.8 Hologic
  • 10.9 Johnson & Johnson
  • 10.10 LightScalpel
  • 10.11 London Bridge Plastic Surgery
  • 10.12 Lumenis
  • 10.13 M A Corporation
  • 10.14 Medline industries, inc.
  • 10.15 Medtronic plc
  • 10.16 Merz Pharma
  • 10.17 Sientra
  • 10.18 Sisram Medical Ltd
  • 10.19 Surgical Holdings Ltd.
  • 10.20 Valeant Pharmaceuticals International
  • 10.21 Zimmer Biomet

List of Tables

  • Table 1 Global Blepharoplasty Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 4 Global Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 5 Global Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 6 Global Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 7 Global Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 8 Global Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 9 Global Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 10 Global Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 11 Global Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 12 Global Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 13 North America Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 14 North America Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 15 North America Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 16 North America Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 17 North America Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 18 North America Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 19 North America Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 20 North America Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 21 North America Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 22 North America Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 23 North America Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 24 North America Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 25 Europe Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Europe Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 Europe Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 28 Europe Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 29 Europe Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 30 Europe Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 31 Europe Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 32 Europe Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 33 Europe Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 34 Europe Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 35 Europe Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 36 Europe Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 37 Asia Pacific Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 39 Asia Pacific Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 40 Asia Pacific Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 41 Asia Pacific Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 42 Asia Pacific Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 43 Asia Pacific Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 44 Asia Pacific Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 45 Asia Pacific Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 46 Asia Pacific Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 47 Asia Pacific Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 48 Asia Pacific Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 49 South America Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 South America Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 51 South America Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 52 South America Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 53 South America Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 54 South America Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 55 South America Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 56 South America Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 57 South America Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 58 South America Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 59 South America Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 60 South America Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
  • Table 61 Middle East & Africa Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Middle East & Africa Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
  • Table 63 Middle East & Africa Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 64 Middle East & Africa Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
  • Table 65 Middle East & Africa Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
  • Table 66 Middle East & Africa Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
  • Table 67 Middle East & Africa Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
  • Table 68 Middle East & Africa Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
  • Table 69 Middle East & Africa Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
  • Table 70 Middle East & Africa Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 71 Middle East & Africa Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 72 Middle East & Africa Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)